Health ❯ Healthcare ❯ Chronic Conditions

Obesity

Weight Management Treatment Options Type 2 Diabetes Health Risks Weight Loss Treatments Weight Loss Medications Weight Regain Cardiovascular Health Treatment Strategies Weight-Related Health Issues

4 ARTICLES

last wk.

Yale Secret‑Shopper Study Finds Little Clinical Oversight at Online GLP‑1 Sellers

The findings show rapid approvals, widespread use of unapproved compounded formulations, automatic shipments with minimal clinical data collection, raising safety and financial concerns.

23 ARTICLES

last wk.

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

3 ARTICLES

last wk.

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

5 ARTICLES

4w ago

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

3 ARTICLES

last mo.

GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease

6 ARTICLES

last mo.

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

3 ARTICLES

5mo ago

Heart Attack Alerts Shift Toward Younger Adults as German Experts Push Prevention

9 ARTICLES

5mo ago

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

9 ARTICLES

5mo ago

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

4 ARTICLES

6mo ago

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

5 ARTICLES

6mo ago

BMJ Review Finds Rapid Weight Regain After Stopping GLP-1 Weight-Loss Injections

9 ARTICLES

7mo ago

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

24 ARTICLES

8mo ago

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

3 ARTICLES

8mo ago

Hypertension in Mexico Is Hitting Younger Adults as Sonora Logs 2025 Increase

Obesity

Yale Secret‑Shopper Study Finds Little Clinical Oversight at Online GLP‑1 Sellers

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease

UAE Becomes First Country Outside U.S. to Offer Wegovy Pill

Cigna Drops GLP-1 Weight-Loss Coverage for Its Employees

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

CMS Pauses Medicare GLP-1 Pilot After Insurers Balk, Sets 2026–27 Bridge

FDA Orders Post-Approval Safety Studies for Lilly’s Foundayo Weight-Loss Pill

Never miss stories about

Obesity

UK Regulators Approve Single-Dose 7.2mg Wegovy Pen for Weekly Use

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

Heart Attack Alerts Shift Toward Younger Adults as German Experts Push Prevention

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

BMJ Review Finds Rapid Weight Regain After Stopping GLP-1 Weight-Loss Injections

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Hypertension in Mexico Is Hitting Younger Adults as Sonora Logs 2025 Increase

Never miss stories about

Obesity